M. Sharaf El-Din

935 total citations
84 papers, 789 citations indexed

About

M. Sharaf El-Din is a scholar working on Analytical Chemistry, Pharmacology and Spectroscopy. According to data from OpenAlex, M. Sharaf El-Din has authored 84 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Analytical Chemistry, 36 papers in Pharmacology and 36 papers in Spectroscopy. Recurrent topics in M. Sharaf El-Din's work include Analytical Methods in Pharmaceuticals (53 papers), Analytical Chemistry and Chromatography (36 papers) and Antibiotics Pharmacokinetics and Efficacy (33 papers). M. Sharaf El-Din is often cited by papers focused on Analytical Methods in Pharmaceuticals (53 papers), Analytical Chemistry and Chromatography (36 papers) and Antibiotics Pharmacokinetics and Efficacy (33 papers). M. Sharaf El-Din collaborates with scholars based in Egypt, Japan and Saudi Arabia. M. Sharaf El-Din's co-authors include Fathalla Belal, Manal Eid, Fawzia Ibrahim, Manar M. Tolba, Khalid A.M. Attia, M. E. K. Wahba, Heba Elmansi, Mohamed M. Y. Kaddah, Abdallah M. Zeid and Nahed El‐Enany and has published in prestigious journals such as The Analyst, Talanta and Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy.

In The Last Decade

M. Sharaf El-Din

80 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Sharaf El-Din Egypt 17 437 306 221 125 115 84 789
Abdalla Shalaby Egypt 16 440 1.0× 302 1.0× 242 1.1× 135 1.1× 109 0.9× 81 810
Saadia M. El‐Ashry Egypt 17 418 1.0× 246 0.8× 212 1.0× 158 1.3× 180 1.6× 47 881
Manal Eid Egypt 19 592 1.4× 378 1.2× 279 1.3× 123 1.0× 132 1.1× 82 1.0k
Rasha M. Youssef Egypt 18 534 1.2× 353 1.2× 226 1.0× 115 0.9× 94 0.8× 50 839
Hoda Mahgoub Egypt 15 472 1.1× 304 1.0× 175 0.8× 134 1.1× 78 0.7× 36 712
Lories I. Bebawy Egypt 16 424 1.0× 279 0.9× 245 1.1× 156 1.2× 75 0.7× 32 641
Azza A. Gazy Egypt 14 471 1.1× 276 0.9× 251 1.1× 155 1.2× 79 0.7× 46 694
Khadiga M. Kelani Egypt 16 426 1.0× 268 0.9× 166 0.8× 148 1.2× 89 0.8× 65 723
Laila Abdel-Fattah Egypt 17 629 1.4× 310 1.0× 384 1.7× 190 1.5× 100 0.9× 54 931
Eglal A. Abdelaleem Egypt 16 514 1.2× 331 1.1× 175 0.8× 126 1.0× 104 0.9× 69 847

Countries citing papers authored by M. Sharaf El-Din

Since Specialization
Citations

This map shows the geographic impact of M. Sharaf El-Din's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sharaf El-Din with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sharaf El-Din more than expected).

Fields of papers citing papers by M. Sharaf El-Din

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sharaf El-Din. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sharaf El-Din. The network helps show where M. Sharaf El-Din may publish in the future.

Co-authorship network of co-authors of M. Sharaf El-Din

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sharaf El-Din. A scholar is included among the top collaborators of M. Sharaf El-Din based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sharaf El-Din. M. Sharaf El-Din is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
El-Din, M. Sharaf, Fawzia Ibrahim, Asmaa Kamal El‐Deen, & Kuniyoshi Shimizu. (2017). Stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of vancomycin hydrochloride in pharmaceuticals and spiked human plasma: Application to degradation kinetics. Journal of Food and Drug Analysis. 26(2). 834–841. 24 indexed citations
4.
El-Din, M. Sharaf, et al.. (2016). NEW VALIDATED SPECTROFLUORIMETRIC AND SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF CLOPIDOGREL IN PHARMACEUTICAL PREPARATIONS USING EOSIN. International Journal of Pharmacy. 6(20). 53–63. 1 indexed citations
6.
Belal, Fathalla, M. Sharaf El-Din, Manar M. Tolba, & Heba Elmansi. (2014). Derivative Spectrophotometric and Liquid Chromatographic Methods for the Simultaneous Determination of Metoclopramide Hydrochloride and Aspirin in Pharmaceuticals. Journal of Chromatographic Science. 52(10). 1224–1232. 13 indexed citations
7.
Belal, Fathalla, M. Sharaf El-Din, Manar M. Tolba, & Heba Elmansi. (2014). Highly sensitive spectrofluorimetric method for the determination of two antimigraine drugs in their tablets and in biological fluids. Application to content uniformity testing. Analytical Methods. 6(8). 2621–2621. 10 indexed citations
9.
Belal, Fathalla, M. Sharaf El-Din, Manar M. Tolba, & Heba Elmansi. (2013). Micelle-Enhanced Spectrofluorimetric Method for Determination of Cyproheptadine Hydrochloride in Tablets: Application to In-Vitro Drug Release and Content Uniformity Test. Journal of Fluorescence. 24(1). 85–91. 17 indexed citations
10.
El-Din, M. Sharaf, et al.. (2012). Validated spectrofluorimetric method for the determination of atorvastatin in pharmaceutical preparations. Journal of Pharmaceutical Analysis. 2(3). 200–205. 25 indexed citations
11.
Walash, M. I., et al.. (2011). Micellar liquid chromatographic method for the simultaneous determination of norfloxacin and tinidazole in pharmaceutical dosage forms and human plasma. Latin American Journal of Pharmacy. 5 indexed citations
12.
Belal, Fathalla, et al.. (2011). Spectrophotometric analysis of a mixture of glyburide and metformin HCl in pharmaceutical preparations. Der pharma chemica. 3(1). 53–64. 6 indexed citations
13.
Ibrahim, Fawzia, M. Sharaf El-Din, Manal Eid, & M. E. K. Wahba. (2011). Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations. Chemistry Central Journal. 5(1). 11–11. 26 indexed citations
14.
El-Din, M. Sharaf, Fawzia Ibrahim, Manal Eid, & M. E. K. Wahba. (2011). Validated Spectroflurimetric Determination of Some H1 Receptor Antagonist Drugs in Pharmaceutical Preparations Through Charge Transfer Complexation. Journal of Fluorescence. 22(1). 175–191. 16 indexed citations
15.
El-Din, M. Sharaf, et al.. (2010). Two different spectrofluorimetric methods for simultaneous determination of gemfibrozil and rosiglitazone in human plasma. Talanta. 82(5). 1708–1716. 7 indexed citations
16.
El‐Shabrawy, Yasser, et al.. (2003). Spectrophotometric determination of fenoterol hydrobromide in pure form and dosage forms. Il Farmaco. 58(10). 1033–1038. 20 indexed citations
17.
El-Din, M. Sharaf, Mustafa A. Abuirjeie, & Mohamed H. Abdel‐Hay. (1991). Simultaneous Determination of Acetaminophen with Orphenadrine Citrate, Ibuprofen or Chlorzoxazone in Combined Dosage Forms by Zero-Crossing Derivative Spectrophotometry. Analytical Letters. 24(12). 2187–2206. 22 indexed citations
18.
El-Din, M. Sharaf, Rudolf Jörg Schaur, & E. Schauenstein. (1988). Uptake of ferrous iron histidinate, a promoter of lipid peroxidation, by Ehrlich ascites tumor cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 962(1). 37–41. 8 indexed citations
19.
Belal, Fathalla, et al.. (1986). Spectrophotometric determination of benzothiadiazines in dosage forms. Talanta. 33(2). 170–172. 9 indexed citations
20.
Neugebauer, Michael, et al.. (1981). Quantitative Dünnschichtchromatographische Analyse von Valepotriaten. Planta Medica. 43(11). 299–301. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026